Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
907.3 USD | +0.80% | +1.47% | +3.31% |
Financials (USD)
Sales 2024 * | 13.88B | Sales 2025 * | 14.84B | Capitalization | 96.73B |
---|---|---|---|---|---|
Net income 2024 * | 4.29B | Net income 2025 * | 4.52B | EV / Sales 2024 * | 6.34 x |
Net cash position 2024 * | 8.68B | Net cash position 2025 * | 13.36B | EV / Sales 2025 * | 5.62 x |
P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
23.1
x | Employees | 13,450 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.74% |
Latest transcript on Regeneron Pharmaceuticals, Inc.
1 day | +0.77% | ||
1 week | +1.64% | ||
Current month | -5.58% | ||
1 month | -5.44% | ||
3 months | -4.80% | ||
6 months | +14.24% | ||
Current year | +3.47% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 88-01-07 | |
Chief Executive Officer | 71 | 88-01-07 | |
Director of Finance/CFO | 54 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christine Poon
BRD | Director/Board Member | 71 | 10-11-11 |
Chief Executive Officer | 71 | 88-01-07 | |
Michael Brown
BRD | Director/Board Member | 82 | 91-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.27% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 907.3 | +0.80% | 340 954 |
24-04-22 | 900.2 | +0.37% | 351,366 |
24-04-19 | 896.8 | +0.32% | 507,466 |
24-04-18 | 894 | -0.80% | 450,630 |
24-04-17 | 901.2 | +0.79% | 468,668 |
Delayed Quote Nasdaq, April 23, 2024 at 10:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.47% | 96.73B | |
-0.22% | 103B | |
+1.51% | 21.31B | |
-15.60% | 21.21B | |
-6.54% | 18.79B | |
-41.41% | 16.37B | |
-22.26% | 13.68B | |
+7.09% | 13.44B | |
+24.18% | 10.98B | |
-22.20% | 8.56B |
- Stock Market
- Equities
- REGN Stock